📋 BridgeBio Pharma, Inc. (BBIO) - Clinical Trial Update
Filing Date: 2022-07-26
Accepted: 2022-07-26 08:00:55
Event Type: Clinical Trial Update
Event Details:
BridgeBio Pharma (BBIO) Announces Clinical Trial Update
BridgeBio Pharma (BBIO) provided an update on its clinical development programs.
Clinical Development Highlights:
Clinical development progress update.
1 weeks for the 62 participants included in the safety population at the time of the interim analysis. The data demonstrated:
At the highest dose level evaluated to date (Cohort 4,
128 mg/kg once daily), the mean increase in annualized height velocity (“AHV”) was +
📋 BridgeBio Pharma, Inc. (BBIO) - Clinical Trial Update
Filing Date: 2022-07-26
Accepted: 2022-07-26 08:00:55
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: